![Lawrence Kenyon](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Lawrence Kenyon
Nessuna posizione attualmente
Patrimonio netto: 67 703 $ in data 31/08/2026
Profilo
Lawrence A. Kenyon served as Chief Financial Officer, Secretary & EVP at NeoPharm, Inc. from 2000 to 2006.
Served as Director at Tamir Biotechnology, Inc. in 2009.
Served as Chief Financial Officer at Par Pharmaceutical, Inc. from 2009 to 2010.
Served as Chief Financial Officer & Executive Vice President at Endo Generics Holdings, Inc. from 2009 to 2010.
Served as President, CEO, CFO & Secretary at Tamir Biotechnology, Inc. in 2013.
Served as Chief Operating & Financial Officer at Arno Therapeutics, Inc. from 2014 to 2015.
Served as CEO, CFO, Secretary, Treasurer & Director at Outlook Therapeutics, Inc. from 2024 to 2025.
Attended the University of Wisconsin, completing undergraduate studies in 1987.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 14/08/2026 | 106.956 ( 0,07% ) | 67 703 $ | 31/08/2026 |
Precedenti posizioni note di Lawrence Kenyon
| Società | Posizione | Fine |
|---|---|---|
| OUTLOOK THERAPEUTICS, INC. | Amministratore Delegato | 01/07/2025 |
| ARNO THERAPEUTICS, INC. | Direttore Finanziario/CFO | 01/09/2015 |
Tamir Biotechnology, Inc.
 Tamir Biotechnology, Inc. Medical SpecialtiesHealth Technology Engages in discovering and developing new class of therapeutic drugs | Amministratore Delegato | 31/03/2013 |
Par Pharmaceutical, Inc.
 Par Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets generic drugs and pharmaceuticals products | Direttore Finanziario/CFO | 01/07/2010 |
| PAR PHARMACEUTICAL COMPANIES, INC. | Direttore Finanziario/CFO | 04/06/2010 |
Formazione di Lawrence Kenyon
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
88
Relazioni di 1° grado
7
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 7 |
|---|---|
Tamir Biotechnology, Inc.
Tamir Biotechnology, Inc. Medical SpecialtiesHealth Technology Engages in discovering and developing new class of therapeutic drugs | Health Technology |
Endo Generics Holdings, Inc.
 Endo Generics Holdings, Inc. Pharmaceuticals: GenericHealth Technology Operates as a holding company with interests in developing, licensing, manufacturing, marketing and distributing generic and branded drugs in the United States | Health Technology |
NeoPharm, Inc.
 NeoPharm, Inc. BiotechnologyHealth Technology Provides drug research, development and commercialization services | Health Technology |
University of Wisconsin
 University of Wisconsin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Par Pharmaceutical, Inc.
Par Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets generic drugs and pharmaceuticals products | Health Technology |
Arno Therapeutics, Inc.
 Arno Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company focused on the clinical development of targeted cancer therapies and novel drug candidates for unmet medical needs | Health Technology |
Outlook Therapeutics, Inc.
 Outlook Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures bevacizumab therapeutic products | Health Technology |
